Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Invesco Galaxy Bitcoin ETF (BTCO) vs Moderna, Inc. (MRNA) Price & Performance

Invesco Galaxy Bitcoin ETFTrade
Moderna, Inc.Trade

Price performance (Past 24H)

Key statistics

Invesco Galaxy Bitcoin ETF vs Moderna, Inc. — how do they compare? Invesco Galaxy Bitcoin ETF trades at $62.92, while Moderna, Inc. trades at $63.69 (market cap $24.18B). The key difference: Moderna, Inc. is trading nearer its 52-week high, Invesco Galaxy Bitcoin ETF nearer its low. Which is the better fit depends on your goals.

BTCOMRNA
Sector
Crypto-linkedHealth
52-Week High
$125.14$81.80
52-Week Low
$58.40$22.36
Market Cap
$24.18B
Enterprise Value
$20.33B

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Invesco Galaxy Bitcoin ETF

BTCO trades at $63.03, down 0.93% for the session. Technical indicators show a bullish trend with moving averages supporting upward momentum, while oscillators remain neutral. The stock faces resistance at $65 with support at $64. Recent financial data shows key valuation and profitability metrics are currently unavailable for analysis.

The stock's technical setup suggests potential for near-term upside if resistance levels are breached. However, the absence of fundamental financial metrics creates significant uncertainty about the company's underlying business performance and valuation. Investors face elevated risk due to limited visibility into financial health and operational metrics.

Moderna, Inc.

Moderna (MRNA) trades at $63.70, up 6.5% recently, with a bullish technical signal and strong moving average support. Despite negative net income margins, the company beat Q2 2026 EPS estimates and secured FDA approval for its mRNA flu vaccine, mFLUSIVA, signaling diversification beyond COVID-19. Revenue has declined from pandemic peaks but is projected to stabilize around $2.2B in 2026.

The outlook is mixed: near-term catalysts from new vaccine approvals and pipeline progress offer upside, but persistent losses and high valuation multiples pose risks. Analyst consensus is cautious with a hold-heavy rating, reflecting uncertainty over profitability timelines amid ongoing R&D investments.

Returns comparison

Trailing returns across standard periods

About Invesco Galaxy Bitcoin ETF

BTCO is a spot Bitcoin ETF that tracks the price of Bitcoin directly. It offers investors a regulated and convenient way to gain exposure to the digital currency through a traditional brokerage account without holding the asset.

Read more on BTCO

About Moderna, Inc.

Moderna, Inc. operates as a clinical stage biotechnology company. The Company focuses on the discovery and development of messenger RNA (mRNA) therapeutics and vaccines. Moderna develops mRNA medicines for infectious, immuno-oncology, and cardiovascular diseases.

Read more on MRNA